Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 1
1986 3
1987 3
1988 8
1989 4
1990 5
1991 4
1992 6
1993 2
1994 2
1995 5
1996 4
1997 7
1998 2
1999 4
2001 1
2002 2
2003 4
2004 3
2005 4
2006 10
2007 4
2008 3
2009 3
2010 5
2011 10
2012 6
2013 7
2014 7
2015 12
2016 7
2017 18
2018 17
2019 14
2020 12
2021 13
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

205 results
Results by year
Filters applied: . Clear all
Page 1
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: shulkin bl. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343642 Free PMC article. Clinical Trial.
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: shulkin bl. Lancet Oncol. 2017 Jul;18(7):946-957. doi: 10.1016/S1470-2045(17)30355-8. Epub 2017 May 23. Lancet Oncol. 2017. PMID: 28549783 Free PMC article. Clinical Trial.
Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial.
Weiss AR, Chen YL, Scharschmidt TJ, Chi YY, Tian J, Black JO, Davis JL, Fanburg-Smith JC, Zambrano E, Anderson J, Arens R, Binitie O, Choy E, Davis JW, Hayes-Jordan A, Kao SC, Kayton ML, Kessel S, Lim R, Meyer WH, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Schlapkohl M, Shulkin BL, Smith EA, Sorger JI, Terezakis S, Hawkins DS, Spunt SL, Wang D. Weiss AR, et al. Among authors: shulkin bl. Lancet Oncol. 2020 Aug;21(8):1110-1122. doi: 10.1016/S1470-2045(20)30325-9. Epub 2020 Jul 20. Lancet Oncol. 2020. PMID: 32702309 Free PMC article. Clinical Trial.
Optimization of Pediatric PET/CT.
Parisi MT, Bermo MS, Alessio AM, Sharp SE, Gelfand MJ, Shulkin BL. Parisi MT, et al. Among authors: shulkin bl. Semin Nucl Med. 2017 May;47(3):258-274. doi: 10.1053/j.semnuclmed.2017.01.002. Epub 2017 Feb 16. Semin Nucl Med. 2017. PMID: 28417855 Review.
Functional-metabolic imaging of neuroblastoma.
Sharp SE, Parisi MT, Gelfand MJ, Yanik GA, Shulkin BL. Sharp SE, et al. Among authors: shulkin bl. Q J Nucl Med Mol Imaging. 2013 Mar;57(1):6-20. Q J Nucl Med Mol Imaging. 2013. PMID: 23474631 Review.
Pediatrics: diagnosis of neuroblastoma.
Sharp SE, Gelfand MJ, Shulkin BL. Sharp SE, et al. Among authors: shulkin bl. Semin Nucl Med. 2011 Sep;41(5):345-53. doi: 10.1053/j.semnuclmed.2011.05.001. Semin Nucl Med. 2011. PMID: 21803184 Review.
PET in pediatric diseases.
Jadvar H, Alavi A, Mavi A, Shulkin BL. Jadvar H, et al. Among authors: shulkin bl. Radiol Clin North Am. 2005 Jan;43(1):135-52. doi: 10.1016/j.rcl.2004.09.008. Radiol Clin North Am. 2005. PMID: 15693653 Review.
The Role of 18F-FDG-PET/CT in Pediatric Sarcoma.
Harrison DJ, Parisi MT, Shulkin BL. Harrison DJ, et al. Among authors: shulkin bl. Semin Nucl Med. 2017 May;47(3):229-241. doi: 10.1053/j.semnuclmed.2016.12.004. Epub 2017 Jan 18. Semin Nucl Med. 2017. PMID: 28417853 Review.
205 results